Equities - Schedule of Stock Option Activity (Detail) - $ / shares |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Number of options | ||||||
| Outstanding and exercisable beginning balance | 153,500 | 307,000 | 460,500 | 629,000 | 926,000 | 2,107,000 |
| Granted | 0 | 0 | 1,825,000 | 120,000 | ||
| Exercised | 0 | (150,000) | (433,000) | (578,000) | ||
| Expired | (153,500) | (153,500) | (153,500) | (18,500) | (1,689,000) | (723,000) |
| Outstanding and exercisable ending balance | 153,500 | 307,000 | 460,500 | 629,000 | 926,000 | |
| Weighted average exercise price | ||||||
| Outstanding and exercisable beginning balance | $ 9.41 | $ 9.41 | $ 9.41 | $ 9.35 | $ 7.98 | $ 9.13 |
| Granted | 0 | 0 | 0 | 0 | 9.41 | 9.57 |
| Exercised | 0 | 0 | 0 | 9.41 | 6.46 | 6.29 |
| Expired | 9.41 | 9.41 | 9.41 | 7.54 | 9.41 | 12.94 |
| Outstanding and exercisable ending balance | 0 | 9.41 | 9.41 | 9.41 | 9.35 | 7.98 |
| Weighted average fair value per option | ||||||
| Outstanding and exercisable beginning balance | 2.98 | 2.73 | 2.48 | 2.22 | 1.72 | 1.82 |
| Granted | 0 | 0 | 0 | 0 | 1.98 | 0.82 |
| Exercised | 0 | 0 | 0 | 1.43 | 1.88 | 1.58 |
| Expired | 2.98 | 2.47 | 1.98 | 1.43 | 1.77 | 1.95 |
| Outstanding and exercisable ending balance | $ 0 | $ 2.98 | $ 2.73 | $ 2.48 | $ 2.22 | $ 1.72 |
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Grant Date Fair Value No definition available.
|
| X | ||||||||||
- Definition Share-based compensation by share-based payment award, options outstanding and exercisable. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation by share-based payment award, options outstanding and exercisable weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|